Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
iTeos Therapeutics is a biopharmaceutical company focused on developing immuno-oncology therapies targeting tumor resistance mechanisms. Its pipeline includes monoclonal antibodies and small molecules designed to enhance immune response against cancer, especially solid tumors. The company collaborates with GSK and others to advance clinical candidates, leveraging expertise in tumor biology, immunology, and translational medicine to create innovative cancer treatments.
This description was generated via AI from an annual report. Updated about 1 year ago.